Compare SXT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXT | HAE |
|---|---|---|
| Founded | 1882 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.8B |
| IPO Year | 1994 | 1996 |
| Metric | SXT | HAE |
|---|---|---|
| Price | $134.02 | $118.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $144.40 | $124.50 |
| AVG Volume (30 Days) | 303.4K | ★ 620.2K |
| Earning Date | 10-30-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.23% | N/A |
| EPS Growth | ★ 7.48 | N/A |
| EPS | ★ 2.24 | 0.72 |
| Revenue | ★ $1,396,499,000.00 | $910,373,000.00 |
| Revenue This Year | $11.85 | $6.21 |
| Revenue Next Year | $13.72 | $5.54 |
| P/E Ratio | ★ $59.44 | $168.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $82.60 | $48.98 |
| 52 Week High | $138.82 | $123.77 |
| Indicator | SXT | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 59.57 | 68.45 |
| Support Level | $131.37 | $100.92 |
| Resistance Level | $137.17 | N/A |
| Average True Range (ATR) | 3.27 | 3.43 |
| MACD | 0.42 | 1.11 |
| Stochastic Oscillator | 68.91 | 79.00 |
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.